Direct E-test (AB biodisk) of respiratory samples improves antimicrobial use in ventilator-associated pneumonia

Clinical Infectious Diseases

Volumn 44, Issue 3, 2007, Pages 382-387

  Bouza, Emilio ^a   Torres, María V ^a   Radice, Celina ^a   Cercemado, Emilia ^a   De Diego, Roberta ^a   Sánchez Csrrillo, Carlos ^a   Muñoz, Patricia ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFEPIME; CIPROFLOXACIN; IMIPENEM; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIARRHEA; DISEASE ASSOCIATION; DOSE TIME EFFECT RELATION; DRUG USE; EARLY DIAGNOSIS; FEMALE; HOSPITAL INFECTION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LOWER RESPIRATORY TRACT; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYSTEM; VENTILATOR ASSOCIATED PNEUMONIA;

AGED; ANTI-BACTERIAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; DRUG COSTS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; REAGENT KITS, DIAGNOSTIC; STAPHYLOCOCCUS AUREUS;

EID: 33846409078     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/510587     Document Type: Article

References (39)

1. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005; 33:2184-93.
2. Myny D, Depuydt P, Colardyn F, Blot S. Ventilator-associated pneumonia in a tertiary care ICU: analysis of risk factors for acquisition and mortality. Acta Clin Belg 2005; 60:114-21.
3. Chastre J. Conference summary: ventilator-associated pneumonia. Respir Care 2005; 50:975-83.
4. Rello J. Bench-to-bedside review: therapeutic options and issues in the management of ventilator-associated bacterial pneumonia. Crit Care 2005; 9:259-65.
5. Park DR. Antimicrobial treatment of ventilator-associated pneumonia. Respir Care 2005; 50:932-55.
6. Kollef MH. Gram-negative bacterial resistance: evolving patterns and treatment paradigms. Clin Infect Dis 2005;40(Suppl 2):S85-8.
7. Kollef MH. Hospital-acquired pneumonia and de-escalation of anti-microbial treatment. Crit Care Med 2001; 29:1473-5.
8. Kollef M. Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time. Drugs 2003; 63:2157-68.
9. Rello J, Vidaur L, Sandiumenge A, et al. De-escalation therapy in ventilator-associated pneumonia. Crit Care Med 2004; 32:2183-90.
10. Fagon JY, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a ran-domized trial. Ann Intern Med 2000; 132:621-30.
11. Cercenado E, Cercenado S, Rico M, Vicente T, Bouza E. Rapid anti-microbial susceptibility testing in patients with ventilator-associated pneumonia: direct E-test on respiratory samples [abstract D-51]. In: Programs and abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) (San Diego, CA). ASM Press: 2002.
12. Zebouh M, Thomas C, Honderlick P, et al. Evaluation of a new E-test method for antimicrobial sensitivity testing of Pseudomonas aeruginosa isolates from cystic fibrosis. Pathol Biol (Paris) 2005; 53:490-4.
13. York MK, Gilligan P. Guidelines for performance of respiratory tract cultures. In: Isenberg HD, ed. Clinical microbiology procedures handbook. 2nd ed., Vol. 1. Washington, DC: ASM Press, 2004:3.11.1.
14. York MK, Gilligan P. Lower respiratory tract cultures. In: Isenberg HD, ed. Clinical microbiology procedures handbook. 2nd ed., Vol. 1. Wash-ington, DC: ASM Press, 2004;3.11.2.
15. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: fifteenth informational supplement. CLSI document M100-SIS, Vol. 25. Wayne, PA: CLSI, 2005.
16. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC defitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-40.
17. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991; 143:1121-9.
18. McCabe W, Jackson G. Gram-negative bacteremia-I. Etiology and ecology. Arch Intern Med 1962; 110:847-55.
19. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-83.
20. Knaus WA, Draper EA, Wagner DA, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-29.
21. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-55.
22. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
23. Kollef MH. What is ventilator-associated pneumonia and why is it important? Respir Care 2005; 50:714-24.
24. Rello J, Diaz E, Rodriguez A. Etiology of ventilator-associated pneumonia. Clin Chest Med 2005; 26:87-95.
25. Bouza E, Perez A, Munoz P, et al. Ventilator-associated pneumonia after heart surgery: a prospective analysis and the value of surveillance. Crit Care Med 2003; 31:1964-70.
26. Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998; 113:412-20.
27. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Intensive Care Med 1996; 22:387-94
28. Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111:676-85.
29. Niederman MS. The clinical diagnosis of ventilator-associated pneumonia. Respir Care 2005; 50:788-96.
30. Kollef MH, Niederman M. Antimicrobial resistance in the ICU: the time for action is now. Crit Care Med 2001;29:63.
31. Torres A, Aznar R, Gatell JM, et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990; 142:523-8.
32. Dupont H, Men tec H, Sollet JP, Bleichner G. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med 2001; 27:355-62.
33. Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001; 134:298-314.
34. Chomarat M, Fredenucci I, Barbe G, et al. Rhone-Alpes observatory of Streptococcus pneumoniae in 1999: 35 cases of meningitis. Pathol Biol (Paris) 2002; 50:595-8.
35. Endtz HP, Van Den Braak N, Van Belkum A, et al. Comparison of eight methods to detect vancomycin resistance in enterococci. J Clin Microbiol 1998; 36:592-4.
36. Ozakin C, Sinirtas M, Sevgican E, Kazak E, Gedikoglu S. Comparison of the E-test method with an automated bacterial identification and antimicrobial susceptibility detection system for screening extended-spectrum beta-lactamase producers. Scand J Infect Dis 2003;35:700-3.
37. Cirillo DM, Piana F, Frisicale L, et al. Direct rapid diagnosis of rifampicin-resistant M. tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif-TB). New Microbiol 2004; 27:221-7.
38. Soloaga R, Defain V Blanco M, et al. Blood cultures: use of presumptive antibiograms. Rev Argent Microbiol 2000; 32:149-52.
39. Torres M, Radice C, Sánchez C, Martín-Rabadán P, Muñoz P, Bouza E. Rendimiento de la tincion de Gram en muestras del tracto respiratorio inferior (TRI) en neumonia asociada a ventilatión mecánica (NAV): estudio prospective [in Spanish]. In: Program and abstracts of the 12th Congress of the Spanish Society for Clinical Microbiology and Infectious Diseases (Valencia, Spain). Madrid: Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica, 2006.